Literature DB >> 22454957

Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.

M Davis1, C J Simmons, B Dordoni, R Williams.   

Abstract

1 Changes in urinary D-glucaric acid excretion following a 14 day course of antipyrine to produce enzyme induction have been compared in normal volunteers with changes in plasma half lives and steady state levels of antipyrine. 2 Urinary D-glucaric acid excretion for the group rose significantly with induction, while there was a significant fall in the mean plasma antipyrine half life and steady state levels. The extent of the increase in urinary D-glucaric acid excretion was inversely related to the pre-induction level, and this also applied to the change in antipyrine half lives. 3 Although in individuals, urinary D-glucaric acid excretion and plasma levels of antipyrine changed in parallel, there was no numerical correlation in the group as a whole between these two tests either before or after enzyme induction. 4 These findings are consistent with other recently reported evidence that plasma drug kinetics and other microsomal enzyme functions are not necessarily affected to the same degree by agents with enzyme inducing properties.

Entities:  

Year:  1974        PMID: 22454957      PMCID: PMC1402553          DOI: 10.1111/j.1365-2125.1974.tb00246.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Metabolism of d-glucuronolactone in mammalian systems. Identification of d-glucaric acid as a normal constituent of urine.

Authors:  C A Marsh
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

2.  Increased hepatic microsomal enzyme activity from occupational exposure to certain organochlorine pesticides.

Authors:  J Hunter; J D Maxwell; D A Stewart; R Williams; J Robinson; A Richardson
Journal:  Nature       Date:  1972-06-16       Impact factor: 49.962

3.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

Authors:  J Hunter; J D Maxwell; M Carrella; D A Stewart; R Williams
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

4.  Pharmacokinetic drug interactions.

Authors:  L F Prescott
Journal:  Lancet       Date:  1969-12-06       Impact factor: 79.321

5.  Urinary D-glucaric acid assay by an improved enzymatic procedure.

Authors:  C J Simmons; M Davis; B Dordoni; R Williams
Journal:  Clin Chim Acta       Date:  1974-02-28       Impact factor: 3.786

6.  Changes in liver blood flow during enzyme induction.

Authors:  E E Ohnhaus; S S Thorgeirsson; D S Davies; A Breckenridge
Journal:  Biochem Pharmacol       Date:  1971-10       Impact factor: 5.858

7.  Immunological studies of Y protein. A major cytoplasmic organic anion-binding protein in rat liver.

Authors:  G Fleischner; J Robbins; I M Arias
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

8.  Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction?

Authors:  J D Maxwell; J Hunter; D A Stewart; S Ardeman; R Williams
Journal:  Br Med J       Date:  1972-01-29

9.  Drug interactions with warfarin: studies with dichloralphenazone, chloral hydrate and phenazone (antipyrine).

Authors:  A Breckenridge; M L Orme; S Thorgeirsson; D S Davies; R V Brooks
Journal:  Clin Sci       Date:  1971-04       Impact factor: 6.124

10.  Altered calcium metabolism in epileptic children on anticonvulsants.

Authors:  J Hunter; J D Maxwell; D A Stewart; V Parsons; R Williams
Journal:  Br Med J       Date:  1971-10-23
View more
  5 in total

1.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

2.  Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.

Authors:  E A Sotaniemi; R O Pelkonen; M Puukka
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

3.  [The pharmacokinetics of digoxin during chronic spironolacton treatment (author's transl)].

Authors:  J P Masson; O Bass; H R Baur; E E Ohnhaus
Journal:  Klin Wochenschr       Date:  1978-11-01

4.  Induction of drug metabolizing enzymes by sulfinpyrazone.

Authors:  E Walter; C Staiger; J de Vries; R Zimmermann; E Weber
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

5.  Glucaric acid excretion. Analysis of the enzymatic assay and findings in smokers and non-smokers.

Authors:  K Fiedler; E Schröter; H Cramer
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.